In vitro and in vivo evaluation of leukoreduced red cell concentrates stored in non‐ DEHP storage bags
Vox Sanguinis · 2026
DOI: 10.1111/vox.70213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, 2026. Verfasst von Stefan F van Wonderen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Blood Preservation, Erythrocytes, Leukocyte Reduction Procedures, Erythrocyte Transfusion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Terumo BCT, Inc. (Terumo Blood and Cell Technologies), Terumo BCT.
Abstract (Originalsprache)
Background and Objectives Europe will ban di(2‐ethylhexyl) phthalate (DEHP), used in blood bags, after 1 July 2030. This two‐phase study assessed the in vitro quality and in vivo 24‐h post‐transfusion recovery (PTR) of whole blood–derived leukoreduced red cell concentrates (RCCs) collected and processed in 1,2‐cyclohexane dicarboxylic acid diisononyl ester (DINCH)‐plasticized sets and stored for 42 days in non‐DEHP Erythromate‐plasticized, a proprietary blend of DINCH and N ‐butyryl‐tri‐ n ‐hexyl citrate (BTHC), disposable sets. Materials and Methods In Phase 1, in vitro parameters of RCCs ( n = 32) stored in non‐DEHP sets containing phosphate‐adenine‐glucose‐guanosine‐saline‐mannitol (PAGGSM) were compared with those of RCCs stored in DEHP sets containing saline‐adenine‐glucose‐mannitol (SAGM) ( n = 24). These parameters were assessed against the European Directorate for the Quality of Medicines & Health Care (EDQM) criteria. In Phase 2, PTR of 42‐day autologous non‐DEHP RCCs was evaluated using biotin‐labelled methods in 24 healthy participants and compared against the EDQM and the US Food and Drug Administration (FDA) criteria. Results Phase 1 results showed that haemoglobin concentrations remained stable. Haemolysis in non‐DEHP/PAGGSM disposable sets was below the EDQM limit (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
- Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
- Department of Product and Process Development, Sanquin Blood Supply Foundation, Amsterdam, The Netherlands.
- Clinical Affairs, Terumo BCT, Inc., Lakewood, Colorado, USA.
- Scientific Affairs, Terumo BCT, Inc., Lakewood, Colorado, USA.
ORCID-Profile: Stefan F van Wonderen, Christie Vermeulen
Förderung
- Terumo BCT, Inc. (Terumo Blood and Cell Technologies)
- Terumo BCT
Zitieren
APA
van Wonderen, S. F., Vermeulen, C., Lagerberg, J., van Amstel, R. B. E., Ribble, L., Sedjo, R. L., Rhodes, J., Clymer, E. J., Vlaar, A. P. J., & Klei, T. R. L. (2026). In vitro and in vivo evaluation of leukoreduced red cell concentrates stored in non‐ DEHP storage bags. Vox Sanguinis. https://doi.org/10.1111/vox.70213
Vancouver
van Wonderen SF, Vermeulen C, Lagerberg J, van Amstel RBE, Ribble L, Sedjo RL, et al. In vitro and in vivo evaluation of leukoreduced red cell concentrates stored in non‐ DEHP storage bags. Vox Sanguinis. 2026. doi:10.1111/vox.70213
BibTeX
@article{vanWonderen2026,
author = {van Wonderen, Stefan F and Vermeulen, Christie and Lagerberg, Johan and van Amstel, Rombout B E and Ribble, Leeann and Sedjo, Rebecca L and Rhodes, Jack and Clymer, E Jane and Vlaar, Alexander P J and Klei, Thomas R L},
title = {In vitro and in vivo evaluation of leukoreduced red cell concentrates stored in non‐ DEHP storage bags},
journal = {Vox Sanguinis},
year = {2026},
doi = {10.1111/vox.70213}
}
EUVIMED